125 related articles for article (PubMed ID: 36257352)
61. Expression and purification of human FANCI and FANCD2 using Escherichia coli cells.
Takahashi D; Sato K; Shimomuki M; Takata M; Kurumizaka H
Protein Expr Purif; 2014 Nov; 103():8-15. PubMed ID: 25168188
[TBL] [Abstract][Full Text] [Related]
62. Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia.
Gravells P; Hoh L; Solovieva S; Patil A; Dudziec E; Rennie IG; Sisley K; Bryant HE
Oncogene; 2013 Nov; 32(46):5338-46. PubMed ID: 23318456
[TBL] [Abstract][Full Text] [Related]
63. Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks.
Shen C; Oswald D; Phelps D; Cam H; Pelloski CE; Pang Q; Houghton PJ
Cancer Res; 2013 Jun; 73(11):3393-401. PubMed ID: 23633493
[TBL] [Abstract][Full Text] [Related]
64. Structural basis of FANCD2 deubiquitination by USP1-UAF1.
Rennie ML; Arkinson C; Chaugule VK; Toth R; Walden H
Nat Struct Mol Biol; 2021 Apr; 28(4):356-364. PubMed ID: 33795880
[TBL] [Abstract][Full Text] [Related]
65. Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage response.
Pradhan A; Ustiyan V; Zhang Y; Kalin TV; Kalinichenko VV
Oncotarget; 2016 Jan; 7(2):1912-26. PubMed ID: 26625197
[TBL] [Abstract][Full Text] [Related]
66. Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival.
Zhao Z; Wang R; Wang R; Song J; Ma F; Pan H; Gao C; Wang D; Chen X; Fan X
BMC Med Genomics; 2024 Mar; 17(1):69. PubMed ID: 38443946
[TBL] [Abstract][Full Text] [Related]
67. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
[TBL] [Abstract][Full Text] [Related]
68. A Fanci knockout mouse model reveals common and distinct functions for FANCI and FANCD2.
Dubois EL; Guitton-Sert L; Béliveau M; Parmar K; Chagraoui J; Vignard J; Pauty J; Caron MC; Coulombe Y; Buisson R; Jacquet K; Gamblin C; Gao Y; Laprise P; Lebel M; Sauvageau G; D d'Andrea A; Masson JY
Nucleic Acids Res; 2019 Aug; 47(14):7532-7547. PubMed ID: 31219578
[TBL] [Abstract][Full Text] [Related]
69. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.
Montes de Oca R; Andreassen PR; Margossian SP; Gregory RC; Taniguchi T; Wang X; Houghtaling S; Grompe M; D'Andrea AD
Blood; 2005 Feb; 105(3):1003-9. PubMed ID: 15454491
[TBL] [Abstract][Full Text] [Related]
70. Differential functions of FANCI and FANCD2 ubiquitination stabilize ID2 complex on DNA.
Rennie ML; Lemonidis K; Arkinson C; Chaugule VK; Clarke M; Streetley J; Spagnolo L; Walden H
EMBO Rep; 2020 Jul; 21(7):e50133. PubMed ID: 32510829
[TBL] [Abstract][Full Text] [Related]
71. Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia.
Rickman KA; Lach FP; Abhyankar A; Donovan FX; Sanborn EM; Kennedy JA; Sougnez C; Gabriel SB; Elemento O; Chandrasekharappa SC; Schindler D; Auerbach AD; Smogorzewska A
Cell Rep; 2015 Jul; 12(1):35-41. PubMed ID: 26119737
[TBL] [Abstract][Full Text] [Related]
72. Silencing of FANCI Promotes DNA Damage and Sensitizes Ovarian Cancer Cells to Carboplatin.
Li Y; Zhang Y; Yang Q; Zhou X; Guo Y; Ding F; Liu Z; Luo A
Curr Cancer Drug Targets; 2022; 22(7):591-602. PubMed ID: 35362384
[TBL] [Abstract][Full Text] [Related]
73. Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.
Berhane H; Epperly MW; Goff J; Kalash R; Cao S; Franicola D; Zhang X; Shields D; Houghton F; Wang H; Wipf P; Parmar K; Greenberger JS
Radiat Res; 2014 Jan; 181(1):76-89. PubMed ID: 24397476
[TBL] [Abstract][Full Text] [Related]
74. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
[TBL] [Abstract][Full Text] [Related]
75. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
Bouffard F; Plourde K; Bélanger S; Ouellette G; Labrie Y; Durocher F
J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
[TBL] [Abstract][Full Text] [Related]
76. Embryonic lethality after combined inactivation of Fancd2 and Mlh1 in mice.
van de Vrugt HJ; Eaton L; Hanlon Newell A; Al-Dhalimy M; Liskay RM; Olson SB; Grompe M
Cancer Res; 2009 Dec; 69(24):9431-8. PubMed ID: 19934329
[TBL] [Abstract][Full Text] [Related]
77. The Fanconi anemia pathway is downregulated upon macrophage differentiation through two distinct mechanisms.
Lu WT; Lemonidis K; Drayton RM; Nouspikel T
Cell Cycle; 2011 Oct; 10(19):3300-10. PubMed ID: 21926477
[TBL] [Abstract][Full Text] [Related]
78. The genetic and biochemical basis of FANCD2 monoubiquitination.
Rajendra E; Oestergaard VH; Langevin F; Wang M; Dornan GL; Patel KJ; Passmore LA
Mol Cell; 2014 Jun; 54(5):858-69. PubMed ID: 24905007
[TBL] [Abstract][Full Text] [Related]
79. C. elegans FANCD2 responds to replication stress and functions in interstrand cross-link repair.
Collis SJ; Barber LJ; Ward JD; Martin JS; Boulton SJ
DNA Repair (Amst); 2006 Nov; 5(11):1398-406. PubMed ID: 16914393
[TBL] [Abstract][Full Text] [Related]
80. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
